Efficacy and Safety of Ensifentrine in Chinese Patients with Chronic Obstructive Pulmonary Disease: The ENHANCE-CHINA Randomized Clinical Trial

20260 citationsJournal Articlehybrid Open Access

Authors

Yumin Zhou · First Affiliated Hospital of Guangzhou Medical University

Charlie Degui Chen · Nuance Communications (Austria)

Zihui Wang · First Affiliated Hospital of Guangzhou Medical University

Fan Wu · First Affiliated Hospital of Guangzhou Medical University

Dongbo Tian · Qingzhou City People's Hospital

Zhu Xiao · Jiangxi Provincial People's Hospital

Jie Cao

Abstract

Ensifentrine significantly improved lung function and showed efficacy benefits in symptoms, quality of life improvement, and exacerbation reduction in Chinese individuals with COPD.

Topics & Keywords

Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary Hypertension Research and Treatments Asthma and respiratory diseases

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: CHEST Journal

DOI: 10.1016/j.chest.2026.02.035

Field-Weighted Citation Impact: 0.00